Consilium news
- Home/
- News & insights/
- Consilium news/
- Consilium Strategic Communications and Sponsors Host 10th Annual...
14 November 2022
Consilium Strategic Communications and Sponsors Host 10th Annual Healthcare Conference: Learning from Tougher Times, Finding a Healthy Future
Three panels on the key issues facing the healthcare sector today
Fireside chat: Justin Stebbing, Professor of oncology and Editor of Oncogene, speaks to Hannah Kuchler, Global Pharmaceuticals Correspondent at the Financial Times
Sponsored by Citi, Cooley and Stifel
Follow the event on Twitter at: #CSCHEALTH22
London, 14 November 2022, Consilium Strategic Communications, a global leader in strategic healthcare communications and investor relations, today hosts its 10th Annual Healthcare Conference: Learning from Tougher Times, Finding a Healthy Future. This year’s conference takes place in person in London and virtually and is co-sponsored by Citi, Cooley and Stifel.
“This year a series of shocks has impacted our industry, the market and the broader economy. As the industry adapts to these developments, it’s clear that the fundamentals of healthcare remain robust and the pace of innovation is accelerating. “Our conference is a great opportunity to gather the best expertise in the industry and to gain broader perspective on the most important issues that affect what we do. We look forward to an insightful and impassioned series of discussions on these important issues in the company of old and new friends.”
Amber Fennell
Partner and Co-Founder of Consilium Strategic Communications“During Consilium’s first 10 years, we have expanded our expert team and capabilities significantly in service of our clients, increased our market share across Europe and the US and enjoyed creating a market-leading position as focused IR and strategic communications advisors to the broad healthcare sector. As always, I’m immensely proud of Consilium’s achievements, all made possible by each dedicated team member who contributes to the firm’s continued growth. I’d like to thank our team for organising what’s set to be another excellent conference today, and of course our speakers and sponsors, and look forward to seeing everyone.”
Mary Jane Elliott
Founder and Managing Partner of Consilium Strategic CommunicationsThe half-day conference is free to attend and will feature three thought-provoking panel discussions with experts at the forefront of healthcare innovation, and a fireside chat.
Our first panel will explore whether ‘hot’ areas of investor focus are a help or hindrance to innovation for those who are at the coalface of clinical development and international investment. The second panel looks at the biggest challenges facing the broader healthcare ecosystem, against the backdrop of rising inflation, and seeks to assess which trends will shape the delivery of healthcare over the next decade. The third panel brings together people with experience of negotiating difficult funding environments to draw together learnings about how to ride the waves.
The event will conclude with a fireside chat in which Professor Justin Stebbing, professor of oncology and Editor of Oncogene, will discuss his thoughts on the next decade in healthcare with the Financial Times’s Global Pharmaceutical Correspondent, Hannah Kuchler.
For those unable to attend in person, the conference will be streamed online, supported by our webcast partner, LSE SparkLive. Registration enquiries for attending in person or online should be addressed to: admincsc@consilium-comms.com.
Conference programme (times in GMT):
|
12:00 - 13:00 |
Lunch and networking |
|
13:00 - 13:05 |
Welcome and conference overview |
|
13:05 - 13:50 |
PANEL 1: Bursting the bubbles? Are hot therapeutic areas of investor focus a help or a hindrance to innovation? |
|
13:50 - 14:35 |
PANEL 2: Reimagining Healthcare: Engineering a healthcare ecosystem for the 21st century |
|
14:35 - 15:20 |
Break |
|
15:20 - 16:05 |
PANEL 3: Managing a downturn, market and financing considerations in a bear market |
|
16:05 - 16:50 |
FIRESIDE CHAT: A discussion between Justin Stebbing and Hannah Kuchler |
|
16:50 - 17:00 |
Closing remarks |
|
17.00 - 18.30 |
Networking drinks |
-ENDS-
To learn more about the event or to register online click here or contact admincsc@consilium-comms.com
For more information about Consilium Strategic Communications:
Mary-Jane Elliott/Amber Fennell
Tel: +44(0)20 3709 5700
Follow us: @consiliumhc
About Consilium Strategic Communications
Consilium Strategic Communications is a global leader in strategic healthcare communications and investor relations advisory with offices in Europe and across the US. Consilium's highly skilled team provides strategic, long-term advice to healthcare companies, Boards, senior decision makers and executives on critical communications and IR programmes and stakeholder challenges. The Company has established deep knowledge across all areas of the global healthcare sector through broad experience in representing international clients spanning the Fortune 500, FTSE 100, FTSEurofirst 300 and FTSE 250, through to discrete specialist reputation management projects. For more information please see www.consilium-comms.com
About Citi
Citi, the leading global bank, has approximately 200 million customer accounts and does business in more than 160 countries and jurisdictions. Citi provides consumers, corporations, governments and institutions with a broad range of financial products and services, including consumer banking and credit, corporate and investment banking, securities brokerage, transaction services, and wealth management.
Additional information may be found at www.citigroup.com | Twitter: @Citi | YouTube: www.youtube.com/citi | Blog: http://blog.citigroup.com | Facebook: www.facebook.com/citi | LinkedIn: www.linkedin.com/company/citi
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law. Cooley has 1,500 lawyers across 18 offices in the United States, Asia, and Europe. Cooley actively represents 1,900+ public and private life sciences company clients worldwide.
About Stifel Financial
Stifel Financial Corp. (NYSE: SF) is a financial services holding company headquartered in St. Louis, Missouri, that conducts its banking, securities, and financial services business through several wholly owned subsidiaries. Stifel’s broker-dealer clients are served in the United States through Stifel, Nicolaus & Company, Incorporated, including its Eaton Partners business division; Keefe, Bruyette & Woods, Inc.; Miller Buckfire & Co., LLC; and Stifel Independent Advisors, LLC. The Company’s broker-dealer affiliates provide securities brokerage, investment banking, trading, investment advisory, and related financial services to individual investors, professional money managers, businesses, and municipalities. Stifel Bank and Stifel Bank & Trust offer a full range of consumer and commercial lending solutions. Stifel Trust Company, N.A. and Stifel Trust Company Delaware, N.A. offer trust and related services. To learn more about Stifel, please visit the Company’s website at www.stifel.com. For global disclosures, please visit https://www.stifel.com/investor-relations/press-releases.
